{"id":46089,"date":"2017-03-21T03:35:21","date_gmt":"2017-03-21T08:35:21","guid":{"rendered":"https:\/\/3768346-fork.findlaw4.flsitebuilder.com\/?p=46089"},"modified":"2017-03-21T03:35:21","modified_gmt":"2017-03-21T08:35:21","slug":"the-seiden-group-announces-u-s-shareholders-formation-of-a-group-to-recover-investor-funds-through-a-possible-receivership-over-china-based-bio-pharm-asia-inc-tickerbfar","status":"publish","type":"post","link":"https:\/\/seidenlaw.com\/ar\/blog\/2017\/03\/the-seiden-group-announces-u-s-shareholders-formation-of-a-group-to-recover-investor-funds-through-a-possible-receivership-over-china-based-bio-pharm-asia-inc-tickerbfar\/","title":{"rendered":"\u0642\u0627\u0646\u0648\u0646 \u0633\u064a\u062f\u064a\u0646 \u064a\u0639\u0644\u0646 \u0639\u0646 \u062a\u0623\u0633\u064a\u0633 \u0645\u062c\u0645\u0648\u0639\u0629 \u0645\u0646 \u0645\u0633\u0627\u0647\u0645\u064a \u0627\u0644\u0648\u0644\u0627\u064a\u0627\u062a \u0627\u0644\u0645\u062a\u062d\u062f\u0629 \u0644\u0627\u0633\u062a\u0631\u062f\u0627\u062f \u0623\u0645\u0648\u0627\u0644 \u0627\u0644\u0645\u0633\u062a\u062b\u0645\u0631\u064a\u0646 \u0645\u0646 \u062e\u0644\u0627\u0644 \u0633\u0644\u0637\u0629 \u0627\u0644\u0625\u062f\u0627\u0631\u0629 \u0627\u0644\u0645\u062d\u062a\u0645\u0644\u0629 \u0644\u0634\u0631\u0643\u0629 Bio-pharm Asia, Inc. (\u0631\u0645\u0632 \u0627\u0644\u062a\u062f\u0627\u0648\u0644:BFAR) \u0627\u0644\u062a\u064a \u062a\u062a\u062e\u0630 \u0645\u0646 \u0627\u0644\u0635\u064a\u0646 \u0645\u0642\u0631\u0627\u064b \u0644\u0647\u0627"},"content":{"rendered":"<p>BioPharm Asia, Inc., (ticker:\u201dBFAR\u201d), is a Nevada corporation involved in the sale of medical products to drug stores, hospitals, neighborhood clinics, and other medicine retail outlets in the People\u2019s Republic of China. BFAR was de-listed from the NASDAQ in June 2013 after it stopped reporting to the Securities &amp; Exchange Commission (\u201cSEC\u201d).<\/p>\n<p>\u062a\u062d\u062f\u062b \u0628\u0639\u0636 \u0627\u0644\u0645\u0633\u0627\u0647\u0645\u064a\u0646 \u0645\u0639 \u0631\u0648\u0628\u0631\u062a \u0648\u0627. \u0633\u064a\u064a\u062f\u064a\u0646\u060c \u0645\u062d\u0627\u0645\u064d \u0641\u064a \u0646\u064a\u0648\u064a\u0648\u0631\u0643\u060c \u0644\u062a\u0645\u062b\u064a\u0644 \u0645\u062c\u0645\u0648\u0639\u0629 \u0645\u0646 \u0627\u0644\u0645\u0633\u0627\u0647\u0645\u064a\u0646 \u0645\u0646 \u0623\u062c\u0644 \u0625\u0646\u0641\u0627\u0630 \u062d\u0642\u0648\u0642 \u0627\u0644\u0645\u0633\u0627\u0647\u0645\u064a\u0646 \u0627\u0644\u0623\u0645\u0631\u064a\u0643\u064a\u064a\u0646 \u0628\u0634\u0623\u0646 \u0623\u0641\u0639\u0627\u0644 \u0636\u0627\u0631\u0629 \u0628\u0627\u0644\u0645\u0633\u062a\u062b\u0645\u0631\u064a\u0646\u060c \u0628\u0645\u0627 \u0641\u064a \u0630\u0644\u0643 \u0639\u062f\u0645 \u062a\u0642\u062f\u064a\u0645 \u0627\u0644\u062a\u0642\u0627\u0631\u064a\u0631 \u0625\u0644\u0649 \u0644\u062c\u0646\u0629 \u0627\u0644\u0623\u0648\u0631\u0627\u0642 \u0627\u0644\u0645\u0627\u0644\u064a\u0629 \u0648\u0627\u0644\u0628\u0648\u0631\u0635\u0627\u062a (SEC) \u0645\u0646 \u0623\u062c\u0644 \u0627\u0644\u062d\u0635\u0648\u0644 \u0639\u0644\u0649 \u0639\u0627\u0626\u062f \u0645\u062d\u062a\u0645\u0644 \u0639\u0644\u0649 \u0631\u0623\u0633 \u0627\u0644\u0645\u0627\u0644 \u0644\u0644\u0645\u0633\u062a\u062b\u0645\u0631\u064a\u0646. . .<\/p>\n<p><a href=\"https:\/\/www.marketwatch.com\/press-release\/the-seiden-group-announces-us-shareholders-formation-of-a-group-to-recover-investor-funds-through-a-possible-receivership-over-china-based-biopharm-asia-inc-ticker-bfar-2017-03-21\" target=\"_blank\" rel=\"noopener\">\u0627\u0642\u0631\u0623 \u0627\u0644\u0645\u0632\u064a\u062f<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>\u062a\u0639\u062f \u0634\u0631\u0643\u0629 BioPharm Asia\u060c Inc. (\u0631\u0645\u0632 \u0627\u0644\u062a\u062f\u0627\u0648\u0644: \u201dBFAR\u201d) \u0634\u0631\u0643\u0629 \u0641\u064a \u0648\u0644\u0627\u064a\u0629 \u0646\u064a\u0641\u0627\u062f\u0627\u060c \u0648\u062a\u062a\u0648\u0644\u0649 \u0628\u064a\u0639 \u0627\u0644\u0645\u0646\u062a\u062c\u0627\u062a \u0627\u0644\u0637\u0628\u064a\u0629 \u0644\u0645\u062a\u0627\u062c\u0631 \u0627\u0644\u0623\u062f\u0648\u064a\u0629 \u0648\u0627\u0644\u0645\u0633\u062a\u0634\u0641\u064a\u0627\u062a \u0648\u0627\u0644\u0639\u064a\u0627\u062f\u0627\u062a \u0627\u0644\u0642\u0631\u0648\u064a\u0629 \u0648\u063a\u064a\u0631\u0647\u0627 \u0645\u0646 \u0645\u062a\u0627\u062c\u0631 \u0628\u064a\u0639 \u0627\u0644\u0623\u062f\u0648\u064a\u0629\u2026<\/p>","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12],"tags":[],"class_list":["post-46089","post","type-post","status-publish","format-standard","hentry","category-firm-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/seidenlaw.com\/ar\/wp-json\/wp\/v2\/posts\/46089","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/seidenlaw.com\/ar\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/seidenlaw.com\/ar\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/seidenlaw.com\/ar\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/seidenlaw.com\/ar\/wp-json\/wp\/v2\/comments?post=46089"}],"version-history":[{"count":0,"href":"https:\/\/seidenlaw.com\/ar\/wp-json\/wp\/v2\/posts\/46089\/revisions"}],"wp:attachment":[{"href":"https:\/\/seidenlaw.com\/ar\/wp-json\/wp\/v2\/media?parent=46089"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/seidenlaw.com\/ar\/wp-json\/wp\/v2\/categories?post=46089"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/seidenlaw.com\/ar\/wp-json\/wp\/v2\/tags?post=46089"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}